Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

GIOTTO · Active aGeIng and Osteoporosis: The next challenge for smarT nanobiOmaterials and 3D technologies

H2020Status: CLOSED1 January 201931 August 2023EU funding €5,660,096Call H2020-NMBP-TR-IND-2018-2020

Osteoporosis is a systemic, degenerative disorder, predominantly affecting postmenopausal women (1 out of 3) but also men at an advanced age (1 out of 5) and it increases the prevalence of fracture risk. One fifth of people suffering an osteoporotic fracture will die within a year and half will become dependent. Appropriate anti-osteoporotic drugs are available but have serious side effects and they do not promote fracture healing.The concept behind GIOTTO is to develop a platform of technologies and materials for the treatment of different types of osteoporotic fractures, designing, manufacturing and validating three different solutions:1)3D graded scaffold, which can be fixated with screws, to treat long bone fractures 2)Fibrous scaffold to deal with small, not confined pelvic fractures;3)Radiopaque, bioresorbable, injectable cement to stabilise vertebral fractures.The three devices will share smart nanobiomaterials that release chemical and biological cues to stimulate bone regeneration while reducing bone loss. Nanofunctionalisation and the smart, temporalised release of active molecules will allow for the systematic cell recruitment and activation needed to face the challenges of stimulating bone tissue regeneration in the elderly. The use of additive manufacturing technologies will enable device personalisation to match and better align with the patient’s anatomy and fracture type. A further boost to meet patient specificity and needs, will be provided through the use of functionalised magnetic nanoparticles in order to provide, via the application of an external oscillating magnetic field, a remote tool to activate mechanotransduction. In parallel, an Internet of Things platform will be developed to gather and collate measurable data inputs about device effectiveness and to provide decision support software as a service to improve the design, manufacture and clinical function of the proposed devices, ultimately managing the overall value chain.

Consortium · 15 organisations

coordinator

POLITECNICO DI TORINO

IT · €920,750

participant

DUBLIN CITY UNIVERSITY

IE · €355,609

participant

BIOMECH INNOVATIONS AG

CH · €622,068

participant

TECNOLOGIA NAVARRA DE NANOPRODUCTOS SL

ES · €263,500

participant

IDRYMA TECHNOLOGIAS KAI EREVNAS

EL · €375,000

participant

UNIVERSITY OF NEWCASTLE UPON TYNE

UK · €362,445

participant

UNIVERSITEIT MAASTRICHT

NL · €392,490

participant

UNIVERSITA DI PISA

IT · €332,000

participant

UNIVERSIDAD COMPLUTENSE DE MADRID

ES · €326,048

participant

BEWARRANT

BE · €324,625

participant

FLUIDINOVA SA

PT · €237,500

participant

BICO GROUP AB

SE · €300,000

participant

NOVAICOS SRLS

IT · €550,313

participant

YODIWO MONOPROSOPI AE

EL · €297,750

thirdParty

TINEXTA INNOVATION HUB S.P.A.

IT

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.